Hill R G
Neurosci Lett. 1981 Jan 20;21(2):217-22. doi: 10.1016/0304-3940(81)90385-2.
Since the discovery of endogenous opioids within the central nervous system much research has been directed towards the demonstration of a physiological control of pain operated by these substances. One way of studying this problem is to challenge the process suspected of being opioid-operated with a specific opiate antagonist, and prior experiments coupled with clinical experience suggested that naloxone was a suitable substance of this type. This short review examines the status of naloxone as an antagonist of endogenous pain control mechanisms and their neuronal correlates, but is not comprehensive. The reader is referred to refs. 4, 29 and 36 for additional detail which space does not allow to be included here.
自从在中枢神经系统中发现内源性阿片类物质以来,许多研究都致力于证明这些物质对疼痛的生理控制作用。研究这个问题的一种方法是用一种特定的阿片拮抗剂来挑战被怀疑由阿片类物质控制的过程,先前的实验以及临床经验表明纳洛酮是这类合适的物质。这篇简短的综述考察了纳洛酮作为内源性疼痛控制机制及其神经元相关物拮抗剂的地位,但并不全面。由于篇幅所限,无法在此包含更多细节,读者可参考参考文献4、29和36。